Connect with us

News

Researchers develop artificial intelligence that can identify cancer cells

Published

on

Scientists from Osaka University in Japan have developed artificial intelligence (AI) that can identify different types of cancers based on microscopy images of their cells. The AI was also able to determine whether the cancer cells were resistant to radiation, and further learned the differences between human and animal cancers. Since the accuracy and timeliness of traditional methods of identifying cancer cells are prone to delays and errors, an accurate and automated system for accomplishing this would be beneficial to cancer research and treatment overall. The results of the scientists’ research were published in the December 2018 issue of Cancer Research.

The type of AI developed for the cell identification is called a convolutional neural network (CNN); it’s loosely based on the connectivity patterns used by neurons in the brain and primarily used for classifying images. As described in their publication, the scientists used a training set of 10,000 images each of human cervical cancer cells (ME-180) and mouse squamous cancer cells (NR-S1), e.g., the thin, flat types of cells found on the surface of the skin and thin linings around various organs throughout the body. They also included images of radioresistant clones with the set, and ultimately obtained a 96% accuracy in a 2,000 image test.

Because the types of cells in a single cancerous tumor can vary widely, identifying the specific cells present is important for determining the best treatment. Thus, having a tool to provide this information quickly and accurately could have a significant impact. The Osaka team hopes to expand the types of cancers their AI can identify and ultimately establish a universal system that can identify all cancer cell types.

Microscopic image of skin cancer cells (squamous) in a mouse (blue). | Credit: Catherine and James Galbraith, Oregon Health and Science University, Knight Cancer Institute/NIH, CC BY-NC 2.0.

Using artificial intelligence in the battle against cancer is being explored throughout the world as the number of uses devised expands. In one notable instance, a team of scientists from The Institute of Cancer Research in London and the University of Edinburgh has developed an AI technique called REVOLVER (repeated evolution of cancer) which identifies DNA mutation patterns in cancers to predict the ways they will change in response to treatment. Similar to how bacteria become resistant to antibiotics, so too can cancers become resistant to the drugs used against them. By removing the unpredictability variable in cancer behavior, scientists would be able to stay ahead of the disease’s progress and tailor treatments accordingly.

The collaboration between AI and healthcare overall is growing, not just in cancer research – even Google is making contributions to the field. Fortunately, the agencies regulating developments are also attuned to the changes. Earlier this year at the AcademyHealth 2018 Health Datapalooza, the U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD signaled the agency’s positive position towards the field. “AI holds enormous promise for the future of medicine, and we’re actively developing a new regulatory framework to promote innovation in this space and support the use of AI-based technologies,” he stated at the event. He also referred to the agency’s plans to streamline their regulations and tools to be sufficiently flexible to handle the rapid pace of advancements and “focus on the ways in which real-world data flows.”

Advertisement

Accidental computer geek, fascinated by most history and the multiplanetary future on its way. Quite keen on the democratization of space. | It's pronounced day-sha, but I answer to almost any variation thereof.

Advertisement
Comments

News

SpaceX reveals date for maiden Starship v3 launch

Published

on

Credit: SpaceX

SpaceX has revealed the date for the maiden voyage of Starship v3, its newest and most advanced version of the rocket yet.

Starship v3 represents a significant leap forward. At 124 meters tall when fully stacked, it stands taller than previous versions and boasts substantial upgrades.

The vehicle incorporates next-generation Raptor 3 engines, which deliver higher thrust, improved reliability, and simplified designs with fewer parts. Both the Super Heavy booster (Booster 19) and the Starship upper stage (Ship 39) feature these enhancements, along with structural improvements for greater payload capacity—exceeding 100 metric tons to low Earth orbit in reusable configuration.

SpaceX and its CEO Elon Musk have announced that the company aims to push the first launch of Starship v3 this Thursday. Musk included some clips of past Starship launches with the announcement.

Advertisement

Advertisement

There are a lot of improvements to Starship v3 from past builds. Key hardware changes include a more robust heat shield, upgraded avionics, and modifications optimized for orbital refueling, a critical technology for future missions to the Moon and Mars. This flight marks the first launch from Starbase’s second orbital pad, allowing parallel operations and accelerating the cadence of tests.

This will be the 12th Starship launch for SpaceX. Flight 12 objectives include a full ascent profile, hot-staging separation, in-space engine relights, and reentry testing. The booster is expected to perform a controlled splashdown in the Gulf of Mexico, while the ship will deploy 20 Starlink simulator satellites and a pair of modified Starlink V3 units before attempting reentry.

Success would validate V3’s design for operational use, paving the way for rapid reusability and higher flight rates.

The rapid evolution from V2 to V3 underscores SpaceX’s iterative approach. Previous flights demonstrated booster catches, ship landings, and heat shield advancements. V3 builds on these with nearly every component refined, supported by an expanding production line at Starbase that churns out vehicles at an unprecedented pace.

Advertisement

Starship V3 is here putting SpaceX closer to Mars than it has ever been

This launch comes amid growing momentum for SpaceX’s ambitious goals. Starship is central to NASA’s Artemis program for lunar landings and Elon Musk’s vision of making humanity multiplanetary. A successful V3 debut would boost confidence in achieving orbital refueling and crewed missions in the coming years.

As excitement builds, enthusiasts and engineers alike await liftoff. Weather and technical readiness will determine the exact timing, but the community is optimistic. Starship V3 is poised to push the boundaries of spaceflight once again, bringing reusable interplanetary transport closer to reality.

Advertisement
Continue Reading

Elon Musk

Elon Musk breaks silence on OpenAI trial decision

Published

on

Gage Skidmore, CC BY-SA 4.0 , via Wikimedia Commons

Elon Musk broke his silence regarding the jury decision to throw out the case against OpenAI and Sam Altman. The Tesla, SpaceX, and xAI frontman has already indicated that an appeal will be filed regarding the decision, which went against him yesterday.

A Federal jury dismissed this high-profile lawsuit after less than two hours of deliberation due to a statute-of-limitations issue.

In a strongly worded post on X on May 18, Musk addressed the federal jury’s dismissal of his high-profile lawsuit against OpenAI, vowing to appeal the ruling to the Ninth Circuit Court of Appeals. The decision, according to Musk, was centered not on the substantive claims but on a statute-of-limitations technicality.

Musk’s lawsuit, filed in 2024, accused OpenAI co-founders Sam Altman and Greg Brockman of breaching the organization’s original nonprofit mission. OpenAI was established in 2015 as a non-profit dedicated to developing artificial intelligence for the benefit of all humanity, with Musk as a key early donor and co-founder before departing in 2018.

Advertisement

Musk alleged that Altman and Brockman improperly shifted the company toward a for-profit model, enriched themselves through massive valuations and partnerships (including with Microsoft), and betrayed founding agreements.

In his post, Musk emphasized that the judge and jury “never actually ruled on the merits of the case, just on a calendar technicality.” He stated unequivocally: “There is no question to anyone following the case in detail that Altman & Brockman did in fact enrich themselves by stealing a charity. The only question is WHEN they did it!”

Musk argued that allowing such actions to stand without review sets a dangerous precedent. “I will be filing an appeal with the Ninth Circuit, because creating a precedent to loot charities is incredibly destructive to charitable giving in America,” he wrote. He reiterated OpenAI’s founding purpose: “OpenAI was founded to benefit all of humanity.”

The jury’s unanimous advisory verdict found that Musk’s claims of breach of charitable trust and unjust enrichment were filed outside California’s three-year statute of limitations. U.S. District Judge Yvonne Gonzalez Rogers adopted the finding and dismissed the case. OpenAI hailed the outcome as vindication, while Musk’s legal team immediately signaled plans to appeal.

The trial, which featured testimony from Musk, Altman, Brockman, Microsoft CEO Satya Nadella, and others, exposed deep rifts in Silicon Valley over AI’s direction.

Advertisement

Musk has long warned that profit-driven AI development, especially with closed models and powerful corporate ties, risks endangering humanity—contrasting it with OpenAI’s original open, safety-focused charter. OpenAI countered that the suit stemmed from business rivalry and that Musk himself had explored for-profit paths earlier.

Musk’s appeal could prolong the saga, potentially affecting OpenAI’s valuation (reportedly over $800 billion) and IPO ambitions. Supporters view his stance as defending nonprofit integrity, while critics see it as sour grapes from a competitor whose own xAI is racing in the AI arena.

Regardless of the legal outcome, the case has spotlighted critical questions about trust, governance, and mission drift in the rapidly evolving AI industry. Musk’s willingness to fight on suggests this chapter is far from closed, with broader implications for how charitable organizations—and the tech giants born from them—operate in the future.

Advertisement
Continue Reading

Elon Musk

NASA updated Artemis III and SpaceX’s role just got more complicated

SpaceX’s Starship is the key to NASA’s Moon plan and the timeline is already slipping.

Published

on

By

SpaceX has been at the center of NASA’s Moon ambitions for five years, and the updated Artemis III plan recently released by NASA makes that relationship more visible than ever. In April 2021, NASA awarded SpaceX a $2.89 billion contract to develop the Starship Human Landing System, selecting it as the sole provider to land astronauts on the Moon under Artemis III. Blue Origin filed legal protests, lost, and eventually received its own contract, but SpaceX was always the program’s primary lander contractor.

The original plan called for Starship to land two astronauts on the lunar south pole. That mission slipped as Starship development ran behind schedule, and in February 2026, NASA officially revised the Artemis III architecture entirely. The mission will now remain in low Earth orbit and serve as a crewed rendezvous and docking test between the Orion spacecraft and both the SpaceX Starship HLS pathfinder and Blue Origin’s Blue Moon Mark 2 pathfinder, with the actual Moon landing pushed to Artemis IV in 2028.

What makes SpaceX’s position particularly significant is the direct line between this week’s Starship V3 launch and the Artemis timeline. The Starship HLS is essentially a modified version of the V3 upper stage, meaning SpaceX cannot realistically prepare a lander for a 2027 docking test until it has demonstrated that the base vehicle flies reliably at scale. Flight 12, targeting this week, is the first data point in that sequence.

SpaceX Board has set a Mars bonus for Elon Musk

Advertisement

NASA has spent nearly $7 billion on Human Landing System development since awarding contracts to SpaceX and Blue Origin in 2021 and 2023, and NASA administrator Jared Isaacman has indicated a desire to drive down costs going forward. As Teslarati reported, before Starship HLS can put anyone on the Moon it has to solve a problem no rocket has demonstrated at scale, which is refueling in orbit, requiring approximately ten tanker launches worth of propellant loaded into a depot before the lander has enough fuel to reach the lunar surface.

The Artemis III mission described by NASA is essentially a stress test for every system that needs to work before any of that happens.

SpaceX has gone from a launch contractor to the single most critical hardware provider in America’s return-to-the-Moon program. With an IPO targeting a $1.75 trillion valuation and Elon Musk’s compensation tied directly to Mars colonization, the pressure on every Starship milestone between now and 2028 has never been higher.

Advertisement
Continue Reading